Diagnosis and management of multiple sclerosis: case studies

Area of Science:

• Neuroscience
• Clinical Neurology
• Immunology

Background:

• Multiple Sclerosis (MS) management has advanced, yet significant clinical challenges persist.
• The primary goals of disease-modifying therapies and research focus on reducing disease activity and disability.
• Current therapeutic strategies primarily target disease activity, not the direct pathophysiology of functional limitations.

Observation:

• Day-to-day functional limitations in MS patients stem from the disease's underlying pathophysiology.
• Demyelination and axonal dysfunction are the core pathological substrates causing these limitations.
• Existing management approaches do not fully address the direct impact of axonal dysfunction on daily life.

Findings:

• Optimizing axonal conduction mechanisms is a potential therapeutic avenue.
• Enhancing the performance and fidelity of axonal function may alleviate MS-related symptoms.
• Targeting axonal dysfunction directly could improve functional capabilities.

Implications:

• Improved understanding of demyelination and axonal dysfunction is crucial for MS patient care.
• Interdisciplinary care models involving patients, families, and clinicians are essential for holistic management.
• Future research should explore strategies to enhance axonal function for better quality of life in chronic neurological diseases like MS.